The role of anti-PD-1/PD-L1 monotherapy as first-line treatment of metastatic NSCLC without targetable mutations and PD-L1 TPS 1–49%
@article{PCM5915,
author = {Arpeet T. Shah and Joel W. Neal},
title = {The role of anti-PD-1/PD-L1 monotherapy as first-line treatment of metastatic NSCLC without targetable mutations and PD-L1 TPS 1–49%},
journal = {Precision Cancer Medicine},
volume = {4},
number = {0},
year = {2020},
keywords = {},
abstract = {},
issn = {2617-2216}, url = {https://pcm.amegroups.org/article/view/5915}
}